Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration

BACKGROUND: Staphylococci represent the first etiologic agents of bone and joint infection (BJI), leading glycopeptides use, especially in case of methicillin-resistance or betalactam intolerance. Teicoplanin may represent an alternative to vancomycin because of its acceptable bone penetration and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Peeters, Olivier, Ferry, Tristan, Ader, Florence, Boibieux, André, Braun, Evelyne, Bouaziz, Anissa, Karsenty, Judith, Forestier, Emmanuel, Laurent, Frédéric, Lustig, Sébastien, Chidiac, Christian, Valour, Florent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093939/
https://www.ncbi.nlm.nih.gov/pubmed/27809799
http://dx.doi.org/10.1186/s12879-016-1955-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093939/
https://www.ncbi.nlm.nih.gov/pubmed/27809799
http://dx.doi.org/10.1186/s12879-016-1955-7

Ejemplares similares